YH-42946
- Generic Name
- YH-42946
A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946
- First Posted Date
- 2024-09-27
- Last Posted Date
- 2025-03-27
- Lead Sponsor
- Yuhan Corporation
- Target Recruit Count
- 161
- Registration Number
- NCT06616766
- Locations
- 🇰🇷
Chungbuk National University Hospital, Cheongju-si, Chungcheongbuk-do, Korea, Republic of
🇰🇷Asan Medical Center, University of Ulsan, Seoul, Korea, Republic of
🇺🇸Next Oncology Virginia, Fairfax, Virginia, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath